- Home
- SO vs BMY Comparison
SO vs BMY Comparison
Compare SO & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SO
- BMY
- Stock Information
- Founded
- SO 1945
- BMY 1887
- Country
- SO United States
- BMY United States
- Employees
- SO N/A
- BMY N/A
- Industry
- SO Power Generation
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- SO Utilities
- BMY Health Care
- Exchange
- SO Nasdaq
- BMY Nasdaq
- Market Cap
- SO 97.0B
- BMY 110.2B
- IPO Year
- SO N/A
- BMY N/A
- Fundamental
- Price
- SO $87.95
- BMY $57.89
- Analyst Decision
- SO Buy
- BMY Hold
- Analyst Count
- SO 17
- BMY 14
- Target Price
- SO $86.94
- BMY $53.92
- AVG Volume (30 Days)
- SO 4.5M
- BMY 12.1M
- Earning Date
- SO 10-31-2024
- BMY 10-31-2024
- Dividend Yield
- SO 3.27%
- BMY 4.12%
- EPS Growth
- SO 55.58
- BMY N/A
- EPS
- SO 4.29
- BMY N/A
- Revenue
- SO $26,428,000,000.00
- BMY $47,435,000,000.00
- Revenue This Year
- SO $6.99
- BMY $6.54
- Revenue Next Year
- SO $3.72
- BMY N/A
- P/E Ratio
- SO $20.49
- BMY N/A
- Revenue Growth
- SO 0.66
- BMY 5.56
- 52 Week Low
- SO $65.80
- BMY $39.35
- 52 Week High
- SO $94.45
- BMY $61.08
- Technical
- Relative Strength Index (RSI)
- SO 44.83
- BMY 59.60
- Support Level
- SO $86.61
- BMY $55.82
- Resistance Level
- SO $89.13
- BMY $59.73
- Average True Range (ATR)
- SO 1.35
- BMY 1.57
- MACD
- SO -0.06
- BMY 0.07
- Stochastic Oscillator
- SO 34.02
- BMY 55.06
About SO Southern Company (The)
Southern is one of the largest utilities in the U.S. The company serves 9 million customers with vertically integrated electric utilities in three states and natural gas distribution utilities in four states. It owns 50 gigawatts of rate-regulated generating capacity, primarily for serving customers in Georgia, Alabama, and Mississippi. Subsidiary Southern Power owns 13 gigawatts of natural gas generation and renewable energy across the U.S. and sells the electricity primarily under long-term contracts.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.